| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.879 | 0.004 | 0.879 | Aldehyde oxidase inhibitor | 0.194 0.108 CID_114851 | ||
| 0.779 | 0.014 | 0.779 | Caspase 9 stimulant | 0.743 0.019 CID_114851 | ||
| 0.711 | 0.003 | 0.711 | GABA C receptor rho-3 antagonist | |||
| 0.693 | 0.003 | 0.693 | Peroxidase inhibitor | 0.111 0.11 CID_114851 | ||
| 0.601 | 0.014 | 0.601 | 5 Hydroxytryptamine release stimulant | 0.496 0.028 CID_114851 | ||
| 0.598 | 0.049 | 0.706 | Apoptosis agonist | 0.706 0.03 CID_114851 | CID_114851 | |
| 0.555 | 0.015 | 0.668 | Histamine release inhibitor | 0.668 0.005 CID_114851 | CID_114851 | |
| 0.543 | 0.003 | 0.543 | Cystathionine beta-synthase inhibitor | 0.398 0.005 CID_114851 | ||
| 0.546 | 0.02 | 0.658 | 5 Hydroxytryptamine release inhibitor | 0.658 0.005 CID_114851 | CID_114851 | |
| 0.524 | 0.017 | 0.524 | Caspase 3 stimulant | 0.426 0.037 CID_114851 | ||
| 0.52 | 0.014 | 0.682 | Free radical scavenger | 0.682 0.005 CID_114851 | CID_114851 | |
| 0.512 | 0.013 | 0.512 | Amyloid beta aggregation inhibitor | 0.222 0.067 CID_114851 | ||
| 0.513 | 0.019 | 0.742 | Antioxidant | 0.742 0.005 CID_114851 | CID_114851 | |
| 0.501 | 0.013 | 0.501 | Superoxide dismutase inhibitor | |||
| 0.517 | 0.03 | 0.713 | Cholesterol antagonist | 0.713 0.007 CID_114851 | CID_114851 | |
| 0.49 | 0.004 | 0.49 | Alcohol oxidase inhibitor | 0.077 0.026 CID_114851 | ||
| 0.486 | 0.004 | 0.486 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.472 | 0.005 | 0.472 | 5 Hydroxytryptamine uptake stimulant | 0.213 0.128 CID_114851 | ||
| 0.469 | 0.002 | 0.469 | Creatine kinase inhibitor | 0.127 0.036 CID_114851 | ||
| 0.492 | 0.031 | 0.492 | Calcium channel L-type activator | |||
| 0.497 | 0.035 | 0.497 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.475 | 0.023 | 0.475 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.448 | 0.007 | 0.679 | Alpha-N-acetylglucosaminidase inhibitor | 0.679 0.003 CID_114851 | CID_114851 | |
| 0.475 | 0.046 | 0.475 | 15-Lipoxygenase inhibitor | |||
| 0.455 | 0.028 | 0.455 | 12-Lipoxygenase inhibitor | |||
| 0.411 | 0.007 | 0.411 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.307 0.022 CID_114851 | ||
| 0.408 | 0.005 | 0.408 | 5-Lipoxygenase inhibitor | |||
| 0.432 | 0.03 | 0.432 | Lipoxygenase inhibitor | |||
| 0.438 | 0.038 | 0.438 | Streptokinase A inhibitor | |||
| 0.437 | 0.039 | 0.437 | MAP kinase kinase 6 inhibitor | |||
| 0.415 | 0.018 | 0.415 | Pyruvate kinase inhibitor | |||
| 0.397 | 0.004 | 0.397 | Porphobilinogen synthase inhibitor | |||
| 0.408 | 0.017 | 0.408 | RNA-directed DNA polymerase inhibitor | 0.309 0.03 CID_114851 | ||
| 0.397 | 0.01 | 0.412 | Topoisomerase II inhibitor | 0.412 0.009 CID_114851 | CID_114851 | |
| 0.392 | 0.005 | 0.392 | GABA C receptor agonist | 0.101 0.066 CID_114851 | ||
| 0.39 | 0.004 | 0.39 | Estrogen receptor beta antagonist | |||
| 0.412 | 0.027 | 0.412 | Hypoxia-inducible factor 1 alpha inhibitor | 0.399 0.03 CID_114851 | ||
| 0.385 | 0.006 | 0.385 | Aldehyde dehydrogenase inhibitor | 0.346 0.008 CID_114851 | ||
| 0.379 | 0.004 | 0.379 | GABA C receptor rho-2 antagonist | |||
| 0.375 | 0.007 | 0.375 | Neurotrophic factor enhancer | 0.347 0.009 CID_114851 | ||
| 0.425 | 0.058 | 0.708 | Transcription factor NF kappa B inhibitor | 0.708 0.019 CID_114851 | CID_114851 | |
| 0.4 | 0.037 | 0.4 | Aryl hydrocarbon receptor agonist | |||
| 0.366 | 0.005 | 0.366 | Estrogen antagonist | 0.102 0.093 CID_114851 | ||
| 0.384 | 0.022 | 0.384 | Sodium/bile acid cotransporter inhibitor | 0.265 0.113 CID_114851 | ||
| 0.386 | 0.03 | 0.386 | Calcium channel activator | |||
| 0.364 | 0.015 | 0.559 | Melanin inhibitor | 0.559 0.005 CID_114851 | CID_114851 | |
| 0.373 | 0.026 | 0.373 | Transcription factor STAT inhibitor | |||
| 0.347 | 0.005 | 0.347 | Succinate dehydrogenase inhibitor | 0.175 0.073 CID_114851 | ||
| 0.375 | 0.034 | 0.375 | DNA damaging | 0.371 0.035 CID_114851 | ||
| 0.451 | 0.11 | 0.839 | Antiinflammatory | 0.839 0.01 CID_114851 | CID_114851 | |
| 0.36 | 0.019 | 0.36 | Dual specificity phosphatase inhibitor | |||
| 0.351 | 0.015 | 0.351 | Mcl-1 antagonist | |||
| 0.392 | 0.058 | 0.392 | Vasodilator, peripheral | 0.388 0.059 CID_114851 | ||
| 0.333 | 0.004 | 0.333 | Phenylalanine 4-hydroxylase inhibitor | 0.065 0.051 CID_114851 | ||
| 0.333 | 0.005 | 0.333 | Histidine decarboxylase inhibitor | |||
| 0.356 | 0.031 | 0.356 | Transcription factor STAT3 inhibitor | |||
| 0.333 | 0.009 | 0.333 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.325 | 0.004 | 0.325 | GABA C receptor antagonist | |||
| 0.328 | 0.009 | 0.328 | Chelator | |||
| 0.325 | 0.008 | 0.453 | Hexokinase inhibitor | 0.453 0.004 CID_114851 | CID_114851 | |
| 0.395 | 0.079 | 0.671 | Antibacterial | 0.671 0.011 CID_114851 | CID_114851 | |
| 0.329 | 0.015 | 0.598 | Amylase inhibitor | 0.598 0.004 CID_114851 | CID_114851 | |
| 0.342 | 0.028 | 0.487 | Cyclic AMP phosphodiesterase inhibitor | 0.487 0.007 CID_114851 | CID_114851 | |
| 0.322 | 0.009 | 0.475 | UDP-glucose 4-epimerase inhibitor | 0.475 0.003 CID_114851 | CID_114851 | |
| 0.326 | 0.014 | 0.419 | NOS3 expression enhancer | 0.419 0.007 CID_114851 | CID_114851 | |
| 0.317 | 0.006 | 0.317 | Topoisomerase II alpha inhibitor | 0.312 0.007 CID_114851 | ||
| 0.342 | 0.032 | 0.503 | DNA synthesis inhibitor | 0.503 0.013 CID_114851 | CID_114851 | |
| 0.314 | 0.012 | 0.314 | Heat shock protein 90 alpha antagonist | |||
| 0.31 | 0.009 | 0.31 | Nitric-oxide synthase stimulant | 0.302 0.011 CID_114851 | ||
| 0.334 | 0.034 | 0.494 | Interleukin agonist | 0.494 0.009 CID_114851 | CID_114851 | |
| 0.3 | 0.005 | 0.3 | Carbonic anhydrase III inhibitor | 0.166 0.023 CID_114851 | ||
| 0.297 | 0.005 | 0.312 | Mannose-6-phosphate isomerase inhibitor | 0.312 0.005 CID_114851 | CID_114851 | |
| 0.308 | 0.018 | 0.384 | Lipid peroxidase inhibitor | 0.384 0.01 CID_114851 | CID_114851 | |
| 0.293 | 0.008 | 0.293 | Carbonic anhydrase XV inhibitor | |||
| 0.296 | 0.013 | 0.296 | NADPH oxidase inhibitor | 0.219 0.029 CID_114851 | ||
| 0.292 | 0.011 | 0.292 | Heat shock protein 90 antagonist | |||
| 0.31 | 0.031 | 0.311 | Anesthetic general | 0.311 0.03 CID_114851 | CID_114851 | |
| 0.323 | 0.046 | 0.323 | Insulysin inhibitor | |||
| 0.282 | 0.005 | 0.282 | Potassium channel (Ca-activated) activator | |||
| 0.294 | 0.018 | 0.543 | Monophenol monooxygenase inhibitor | 0.543 0.006 CID_114851 | CID_114851 | |
| 0.337 | 0.062 | 0.534 | Vasodilator, coronary | 0.534 0.012 CID_114851 | CID_114851 | |
| 0.337 | 0.062 | 0.577 | Apoptosis antagonist | 0.577 0.012 CID_114851 | CID_114851 | |
| 0.277 | 0.004 | 0.277 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.317 | 0.045 | 0.317 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.276 | 0.005 | 0.276 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.275 | 0.004 | 0.275 | GABA C receptor rho-1 antagonist | |||
| 0.28 | 0.01 | 0.28 | Interleukin 4 antagonist | 0.167 0.037 CID_114851 | ||
| 0.298 | 0.029 | 0.575 | Non-steroidal antiinflammatory agent | 0.575 0.005 CID_114851 | CID_114851 | |
| 0.273 | 0.004 | 0.273 | Alpha tubulin antagonist | |||
| 0.289 | 0.021 | 0.289 | Protein-tyrosine phosphatase inhibitor | 0.196 0.048 CID_114851 | ||
| 0.273 | 0.005 | 0.273 | Estrogen agonist | 0.096 0.018 CID_114851 | ||
| 0.315 | 0.048 | 0.743 | Hypoglycemic | 0.743 0.004 CID_114851 | CID_114851 | |
| 0.272 | 0.005 | 0.272 | CF transmembrane conductance regulator agonist | 0.176 0.04 CID_114851 | ||
| 0.285 | 0.02 | 0.285 | Phospholipase C inhibitor | 0.215 0.035 CID_114851 | ||
| 0.286 | 0.021 | 0.286 | Tubulin antagonist | |||
| 0.292 | 0.029 | 0.406 | DNA methyltransferase I inhibitor | 0.406 0.009 CID_114851 | CID_114851 | |
| 0.268 | 0.01 | 0.434 | ATPase inhibitor | 0.434 0.003 CID_114851 | CID_114851 | |
| 0.259 | 0.003 | 0.259 | DOPA decarboxylase inhibitor | |||
| 0.261 | 0.007 | 0.261 | Alcohol dehydrogenase inhibitor | 0.193 0.013 CID_114851 | ||
| 0.289 | 0.037 | 0.289 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.261 | 0.012 | 0.261 | Ferrochelatase inhibitor | |||
| 0.253 | 0.005 | 0.253 | Beta tubulin antagonist | |||
| 0.262 | 0.015 | 0.352 | Topoisomerase I inhibitor | 0.352 0.008 CID_114851 | CID_114851 | |
| 0.335 | 0.088 | 0.335 | Prostaglandin dehydrogenase inhibitor | |||
| 0.297 | 0.052 | 0.367 | Antiamyloidogenic | 0.367 0.035 CID_114851 | CID_114851 | |
| 0.257 | 0.013 | 0.257 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.278 | 0.035 | 0.418 | DNA methylase inhibitor | 0.418 0.01 CID_114851 | CID_114851 | |
| 0.264 | 0.021 | 0.264 | Histone acetyltransferase inhibitor | |||
| 0.248 | 0.01 | 0.347 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.347 0.005 CID_114851 | CID_114851 | |
| 0.333 | 0.095 | 0.553 | Immunosuppressant | 0.553 0.02 CID_114851 | CID_114851 | |
| 0.241 | 0.005 | 0.241 | Potassium channel large-conductance Ca-activated activator | |||
| 0.282 | 0.047 | 0.282 | Gastrin inhibitor | 0.219 0.12 CID_114851 | ||
| 0.242 | 0.007 | 0.466 | Triose-phosphate isomerase inhibitor | 0.466 0.003 CID_114851 | CID_114851 | |
| 0.261 | 0.026 | 0.406 | Interferon gamma antagonist | 0.406 0.01 CID_114851 | CID_114851 | |
| 0.288 | 0.057 | 0.288 | Dyrk kinase inhibitor | |||
| 0.236 | 0.007 | 0.236 | HIV-1 integrase (3'-Processing) inhibitor | 0.078 0.035 CID_114851 | ||
| 0.232 | 0.003 | 0.232 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.233 | 0.005 | 0.233 | Prolactin inhibitor | |||
| 0.358 | 0.132 | 0.561 | Alpha-glucosidase inhibitor | 0.561 0.063 CID_114851 | CID_114851 | |
| 0.297 | 0.071 | 0.427 | Spasmolytic | 0.427 0.035 CID_114851 | CID_114851 | |
| 0.237 | 0.012 | 0.237 | Toll-Like receptor 2 antagonist | 0.111 0.088 CID_114851 | ||
| 0.233 | 0.008 | 0.233 | 5 Hydroxytryptamine 3A agonist | |||
| 0.229 | 0.007 | 0.229 | Estrogen receptor alpha antagonist | |||
| 0.232 | 0.011 | 0.232 | Arachidonic acid antagonist | 0.187 0.047 CID_114851 | ||
| 0.242 | 0.022 | 0.242 | MAO A inhibitor | |||
| 0.234 | 0.015 | 0.234 | Catenin beta inhibitor | 0.146 0.115 CID_114851 | ||
| 0.257 | 0.038 | 0.257 | Dual specificity phosphatase 3 inhibitor | |||
| 0.231 | 0.014 | 0.321 | Xanthine oxidase inhibitor | 0.321 0.006 CID_114851 | CID_114851 | |
| 0.249 | 0.035 | 0.249 | Insulin sensitizer | 0.218 0.056 CID_114851 | ||
| 0.225 | 0.01 | 0.225 | Carbonic anhydrase VI inhibitor | 0.095 0.042 CID_114851 | ||
| 0.223 | 0.009 | 0.285 | Photosensitizer | 0.285 0.004 CID_114851 | CID_114851 | |
| 0.236 | 0.023 | 0.236 | Neurotensin receptor agonist | |||
| 0.265 | 0.053 | 0.265 | Psychostimulant | 0.247 0.06 CID_114851 | ||
| 0.261 | 0.049 | 0.524 | Nitric oxide antagonist | 0.524 0.014 CID_114851 | CID_114851 | |
| 0.239 | 0.03 | 0.239 | MAO inhibitor | |||
| 0.215 | 0.006 | 0.215 | Glutamate decarboxylase inhibitor | 0.064 0.063 CID_114851 | ||
| 0.27 | 0.061 | 0.841 | Angiogenesis stimulant | 0.841 0.003 CID_114851 | CID_114851 | |
| 0.23 | 0.021 | 0.23 | Cholesterol synthesis inhibitor | 0.149 0.045 CID_114851 | ||
| 0.297 | 0.09 | 0.716 | Antithrombotic | 0.716 0.007 CID_114851 | CID_114851 | |
| 0.23 | 0.025 | 0.23 | Cyclooxygenase 1 inhibitor | 0.112 0.088 CID_114851 | ||
| 0.214 | 0.009 | 0.426 | NADH dehydrogenase inhibitor | 0.426 0.004 CID_114851 | CID_114851 | |
| 0.21 | 0.009 | 0.21 | HIV-1 integrase (Strand Transfer) inhibitor | 0.07 0.036 CID_114851 | ||
| 0.232 | 0.031 | 0.419 | Protein kinase stimulant | 0.419 0.007 CID_114851 | CID_114851 | |
| 0.208 | 0.008 | 0.208 | Keratolytic | |||
| 0.204 | 0.004 | 0.204 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.22 | 0.021 | 0.231 | DNA intercalator | 0.231 0.019 CID_114851 | CID_114851 | |
| 0.209 | 0.01 | 0.209 | Adenylate cyclase stimulant | 0.16 0.048 CID_114851 | ||
| 0.251 | 0.053 | 0.251 | MAP kinase kinase 2 inhibitor | |||
| 0.201 | 0.005 | 0.201 | Estrogen receptor beta agonist | 0.05 0.019 CID_114851 | ||
| 0.205 | 0.01 | 0.471 | AMP-activated protein kinase stimulant | 0.471 0.003 CID_114851 | CID_114851 | |
| 0.195 | 0.004 | 0.195 | Ca2+-transporting ATPase inhibitor | 0.19 0.004 CID_114851 | ||
| 0.201 | 0.01 | 0.201 | TRPA1 agonist | 0.153 0.029 CID_114851 | ||
| 0.205 | 0.017 | 0.509 | Cyclooxygenase 3 inhibitor | 0.509 0.003 CID_114851 | CID_114851 | |
| 0.213 | 0.025 | 0.399 | Cell wall synthesis inhibitor | 0.399 0.006 CID_114851 | CID_114851 | |
| 0.301 | 0.114 | 0.301 | Calpain 2 inhibitor | |||
| 0.202 | 0.015 | 0.202 | Adenylate kinase inhibitor | 0.16 0.023 CID_114851 | ||
| 0.213 | 0.026 | 0.213 | Protein-tyrosine phosphatase 1B inhibitor | 0.185 0.033 CID_114851 | ||
| 0.191 | 0.005 | 0.191 | CDC25B inhibitor | |||
| 0.204 | 0.018 | 0.204 | Nav1.6 sodium channel blocker | |||
| 0.208 | 0.024 | 0.208 | Adenylate cyclase inhibitor | 0.146 0.048 CID_114851 | ||
| 0.188 | 0.005 | 0.188 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.19 | 0.008 | 0.19 | CDC25A inhibitor | |||
| 0.222 | 0.041 | 0.222 | Tumour necrosis factor antagonist | |||
| 0.183 | 0.004 | 0.183 | D-Ala-D-Ala ligase inhibitor | |||
| 0.243 | 0.064 | 0.243 | Interleukin antagonist | |||
| 0.194 | 0.014 | 0.194 | Telomerase inhibitor | |||
| 0.192 | 0.017 | 0.192 | Catalase inhibitor | |||
| 0.185 | 0.01 | 0.188 | Heat shock protein 70 antagonist | 0.188 0.009 CID_114851 | CID_114851 | |
| 0.188 | 0.014 | 0.473 | Beta glucuronidase inhibitor | 0.473 0.004 CID_114851 | CID_114851 | |
| 0.2 | 0.026 | 0.338 | Alkylator | 0.338 0.01 CID_114851 | CID_114851 | |
| 0.191 | 0.018 | 0.191 | MAP kinase kinase 4 inhibitor | |||
| 0.208 | 0.036 | 0.301 | Interleukin 6 antagonist | 0.301 0.014 CID_114851 | CID_114851 | |
| 0.203 | 0.032 | 0.203 | Alkaline phosphatase inhibitor | 0.194 0.035 CID_114851 | ||
| 0.238 | 0.067 | 0.238 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.217 | 0.047 | 0.217 | Amyloid beta precursor protein antagonist | |||
| 0.175 | 0.005 | 0.175 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.17 0.005 CID_114851 | ||
| 0.192 | 0.023 | 0.192 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.184 | 0.016 | 0.21 | Carbonic anhydrase XIII inhibitor | 0.21 0.013 CID_114851 | CID_114851 | |
| 0.181 | 0.013 | 0.356 | DNA repair enzyme inhibitor | 0.356 0.004 CID_114851 | CID_114851 | |
| 0.181 | 0.014 | 0.181 | Protein kinase C zeta inhibitor | |||
| 0.175 | 0.01 | 0.175 | Macrophage migration inhibitory factor inhibitor | |||
| 0.176 | 0.011 | 0.176 | Transcription factor STAT6 inhibitor | |||
| 0.168 | 0.004 | 0.168 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.169 | 0.006 | 0.196 | Glutamate release inhibitor | 0.196 0.005 CID_114851 | CID_114851 | |
| 0.203 | 0.041 | 0.203 | Cyclooxygenase inhibitor | |||
| 0.183 | 0.021 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.229 | 0.068 | 0.445 | Peptidyltransferase inhibitor | 0.445 0.005 CID_114851 | CID_114851 | |
| 0.216 | 0.056 | 0.579 | Hepatoprotectant | 0.579 0.005 CID_114851 | CID_114851 | |
| 0.191 | 0.031 | 0.191 | DNA polymerase I inhibitor | 0.183 0.034 CID_114851 | ||
| 0.174 | 0.014 | 0.3 | Phosphofructokinase-1 inhibitor | 0.3 0.005 CID_114851 | CID_114851 | |
| 0.175 | 0.016 | 0.175 | Sphingomyelinase inhibitor | 0.132 0.033 CID_114851 | ||
| 0.217 | 0.058 | 0.217 | I kappa B kinase epsilon inhibitor | |||
| 0.232 | 0.074 | 0.232 | Neuropeptide Y2 antagonist | |||
| 0.177 | 0.02 | 0.177 | Protein kinase C gamma inhibitor | |||
| 0.185 | 0.027 | 0.185 | MAO B inhibitor | |||
| 0.177 | 0.02 | 0.191 | Mucolytic | 0.191 0.015 CID_114851 | CID_114851 | |
| 0.161 | 0.005 | 0.161 | Estrogen receptor alpha agonist | |||
| 0.205 | 0.049 | 0.205 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.255 | 0.101 | 0.255 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.249 | 0.096 | 0.529 | Immunostimulant | 0.529 0.025 CID_114851 | CID_114851 | |
| 0.166 | 0.013 | 0.166 | Glutamate dehydrogenase inhibitor | 0.101 0.03 CID_114851 | ||
| 0.308 | 0.156 | 0.849 | Cyclophilin D inhibitor | 0.849 0.005 CID_114851 | CID_114851 | |
| 0.173 | 0.022 | 0.173 | Vanilloid 1 agonist | 0.164 0.027 CID_114851 | ||
| 0.189 | 0.037 | 0.475 | Hemostatic | 0.475 0.005 CID_114851 | CID_114851 | |
| 0.154 | 0.003 | 0.154 | Dopamine D5 agonist | |||
| 0.156 | 0.006 | 0.156 | Purinergic P2X1 antagonist | 0.089 0.021 CID_114851 | ||
| 0.232 | 0.082 | 0.232 | Calpain inhibitor | |||
| 0.169 | 0.021 | 0.169 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.162 | 0.013 | 0.162 | CYP2A6 inhibitor | |||
| 0.232 | 0.084 | 0.523 | Tumour necrosis factor alpha release inhibitor | 0.523 0.012 CID_114851 | CID_114851 | |
| 0.153 | 0.005 | 0.153 | Topoisomerase II beta inhibitor | 0.108 0.008 CID_114851 | ||
| 0.194 | 0.046 | 0.194 | Phospholipase A2 inhibitor | 0.171 0.059 CID_114851 | ||
| 0.153 | 0.007 | 0.153 | GABA aminotransferase inhibitor | 0.143 0.009 CID_114851 | ||
| 0.159 | 0.014 | 0.159 | Anabolic | 0.097 0.067 CID_114851 | ||
| 0.165 | 0.019 | 0.196 | Uric acid excretion stimulant | 0.196 0.014 CID_114851 | CID_114851 | |
| 0.149 | 0.005 | 0.149 | Heat shock protein 90 beta antagonist | |||
| 0.166 | 0.022 | 0.166 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.146 | 0.006 | 0.146 | CD45 antagonist | |||
| 0.147 | 0.006 | 0.147 | NMDA receptor subunit 3B antagonist | |||
| 0.165 | 0.026 | 0.165 | Interleukin 8 antagonist | |||
| 0.143 | 0.005 | 0.143 | GABA B receptor agonist | |||
| 0.145 | 0.008 | 0.145 | Xanthine dehydrogenase inhibitor | 0.073 0.029 CID_114851 | ||
| 0.168 | 0.031 | 0.168 | Aminopeptidase B inhibitor | |||
| 0.142 | 0.005 | 0.142 | Estrogen-related receptor beta agonist | |||
| 0.166 | 0.029 | 0.493 | Expectorant | 0.493 0.004 CID_114851 | CID_114851 | |
| 0.145 | 0.009 | 0.145 | HIV-1 integrase inhibitor | |||
| 0.158 | 0.023 | 0.158 | Caspase 3 inhibitor | |||
| 0.204 | 0.073 | 0.204 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.165 | 0.036 | 0.165 | Antibacterial (Helicobacter pylori) | |||
| 0.132 | 0.003 | 0.132 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.133 | 0.005 | 0.133 | Fatty acid synthase inhibitor | 0.063 0.032 CID_114851 | ||
| 0.157 | 0.03 | 0.157 | Nav1.1 sodium channel blocker | |||
| 0.143 | 0.017 | 0.143 | Histamine N-methyltransferase inhibitor | |||
| 0.145 | 0.019 | 0.156 | Thioredoxin inhibitor | 0.156 0.015 CID_114851 | CID_114851 | |
| 0.145 | 0.021 | 0.145 | Electrolyte absorption antagonist | |||
| 0.14 | 0.016 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.148 | 0.024 | 0.148 | Breast cancer-resistant protein inhibitor | |||
| 0.127 | 0.005 | 0.127 | Aconitate hydratase inhibitor | 0.049 0.04 CID_114851 | ||
| 0.146 | 0.025 | 0.146 | Urease inhibitor | |||
| 0.19 | 0.068 | 0.19 | LIM domain kinase 1 inhibitor | |||
| 0.162 | 0.041 | 0.162 | Farnesoid X receptor antagonist | |||
| 0.131 | 0.01 | 0.131 | Glycine receptor agonist | 0.114 0.014 CID_114851 | ||
| 0.132 | 0.012 | 0.165 | Glycine receptor antagonist | 0.165 0.005 CID_114851 | CID_114851 | |
| 0.124 | 0.004 | 0.124 | MAP kinase kinase 7 inhibitor | |||
| 0.158 | 0.04 | 0.158 | Pregnane X receptor agonist | |||
| 0.158 | 0.04 | 0.158 | Cathepsin H inhibitor | |||
| 0.134 | 0.016 | 0.17 | Phosphodiesterase 6D inhibitor | 0.17 0.006 CID_114851 | CID_114851 | |
| 0.146 | 0.028 | 0.169 | CC chemokine 6 receptor antagonist | 0.169 0.008 CID_114851 | CID_114851 | |
| 0.129 | 0.011 | 0.129 | Carbonic anhydrase VB inhibitor | |||
| 0.141 | 0.023 | 0.144 | Acetylcholine release stimulant | 0.144 0.021 CID_114851 | CID_114851 | |
| 0.164 | 0.047 | 0.164 | Acetylcholinesterase inhibitor | |||
| 0.128 | 0.012 | 0.128 | Biliverdin reductase inhibitor | 0.088 0.023 CID_114851 | ||
| 0.137 | 0.022 | 0.137 | MAP kinase kinase 1 inhibitor | |||
| 0.131 | 0.015 | 0.131 | Myeloperoxidase inhibitor | |||
| 0.127 | 0.013 | 0.132 | T cell inhibitor | 0.132 0.012 CID_114851 | CID_114851 | |
| 0.128 | 0.014 | 0.128 | Carbamoyl phosphate synthetase inhibitor | 0.075 0.031 CID_114851 | ||
| 0.16 | 0.047 | 0.16 | Cyclooxygenase 2 inhibitor | |||
| 0.152 | 0.039 | 0.152 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.122 | 0.011 | 0.146 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.146 0.009 CID_114851 | CID_114851 | |
| 0.162 | 0.051 | 0.162 | Nav1.2 sodium channel blocker | |||
| 0.13 | 0.019 | 0.13 | Carbonic anhydrase V inhibitor | |||
| 0.126 | 0.016 | 0.145 | ATPase (Vacuolar H+) inhibitor | 0.145 0.009 CID_114851 | CID_114851 | |
| 0.143 | 0.032 | 0.321 | Antineoplastic antibiotic | 0.321 0.008 CID_114851 | CID_114851 | |
| 0.117 | 0.007 | 0.117 | NMDA receptor subunit 3A antagonist | |||
| 0.115 | 0.005 | 0.115 | Glutamate (mGluR7) antagonist | |||
| 0.16 | 0.052 | 0.16 | Bone formation stimulant | 0.114 0.091 CID_114851 | ||
| 0.127 | 0.019 | 0.127 | Glutathione S-transferase inhibitor | |||
| 0.146 | 0.039 | 0.198 | Microtubule formation inhibitor | 0.198 0.02 CID_114851 | CID_114851 | |
| 0.117 | 0.011 | 0.117 | Maillard reaction inhibitor | |||
| 0.238 | 0.132 | 0.238 | Thyroid hormone antagonist | |||
| 0.127 | 0.021 | 0.127 | Ornithine decarboxylase inhibitor | 0.104 0.041 CID_114851 | ||
| 0.135 | 0.029 | 0.135 | NMDA receptor antagonist | |||
| 0.165 | 0.06 | 0.365 | Insulin secretagoues | 0.365 0.008 CID_114851 | CID_114851 | |
| 0.122 | 0.017 | 0.122 | Aromatase inhibitor | |||
| 0.144 | 0.039 | 0.144 | Falcipain 3 inhibitor | |||
| 0.163 | 0.058 | 0.163 | Thiol protease inhibitor | |||
| 0.113 | 0.009 | 0.113 | Phospholipase D inhibitor | |||
| 0.116 | 0.015 | 0.122 | Aldose reductase inhibitor | 0.122 0.014 CID_114851 | CID_114851 | |
| 0.158 | 0.056 | 0.158 | Cytokine production inhibitor | |||
| 0.13 | 0.029 | 0.13 | Androgen antagonist | |||
| 0.121 | 0.02 | 0.121 | Dopamine D1 antagonist | |||
| 0.119 | 0.018 | 0.119 | Carbonic anhydrase VA inhibitor | |||
| 0.129 | 0.029 | 0.129 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.112 | 0.012 | 0.112 | CC chemokine 5 receptor agonist | |||
| 0.164 | 0.066 | 0.164 | Cytidine deaminase inhibitor | |||
| 0.114 | 0.016 | 0.114 | Argininosuccinate synthase inhibitor | 0.078 0.026 CID_114851 | ||
| 0.117 | 0.02 | 0.117 | Aminopeptidase I inhibitor | |||
| 0.105 | 0.009 | 0.105 | Glutamate (mGluR6) antagonist | 0.068 0.045 CID_114851 | ||
| 0.121 | 0.025 | 0.121 | Adrenaline agonist | |||
| 0.114 | 0.019 | 0.114 | Thioredoxin reductase inhibitor | |||
| 0.139 | 0.045 | 0.139 | Alpha 2b adrenoreceptor antagonist | |||
| 0.105 | 0.011 | 0.105 | Aryl hydrocarbon receptor antagonist | |||
| 0.151 | 0.057 | 0.151 | Interleukin 1 antagonist | |||
| 0.098 | 0.005 | 0.098 | Dihydroorotate oxidase inhibitor | |||
| 0.155 | 0.063 | 0.155 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.115 | 0.024 | 0.115 | Bile acid receptor antagonist | |||
| 0.138 | 0.049 | 0.138 | Protein kinase (CK2) alpha inhibitor | |||
| 0.104 | 0.015 | 0.104 | Acyl-CoA dehydrogenase inhibitor | 0.055 0.038 CID_114851 | ||
| 0.114 | 0.026 | 0.114 | NMDA 2 receptor antagonist | |||
| 0.159 | 0.071 | 0.159 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.1 | 0.013 | 0.1 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.101 | 0.014 | 0.101 | Beta 3 adrenoreceptor antagonist | |||
| 0.108 | 0.022 | 0.108 | Leukotriene synthesis inhibitor | |||
| 0.095 | 0.008 | 0.095 | Transcription factor RelA inhibitor | |||
| 0.157 | 0.071 | 0.301 | Diuretic | 0.301 0.022 CID_114851 | CID_114851 | |
| 0.108 | 0.022 | 0.108 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.101 | 0.016 | 0.101 | Vanilloid 4 agonist | |||
| 0.222 | 0.137 | 0.222 | Thyroid hormone beta antagonist | |||
| 0.138 | 0.053 | 0.138 | Proteasome inhibitor | |||
| 0.125 | 0.041 | 0.125 | Electron transport complex I inhibitor | |||
| 0.098 | 0.014 | 0.098 | NMDA 2A receptor antagonist | |||
| 0.1 | 0.016 | 0.1 | NMDA receptor glycine site agonist | |||
| 0.163 | 0.08 | 0.163 | Antipruritic | |||
| 0.087 | 0.005 | 0.087 | Pregnane X receptor antagonist | |||
| 0.09 | 0.008 | 0.09 | DNA helicase inhibitor | 0.056 0.034 CID_114851 | ||
| 0.087 | 0.005 | 0.087 | Adenylate cyclase 1 inhibitor | |||
| 0.098 | 0.017 | 0.098 | NMDA 2C receptor antagonist | |||
| 0.088 | 0.007 | 0.133 | Glucose-6-phosphate isomerase inhibitor | 0.133 0.003 CID_114851 | CID_114851 | |
| 0.139 | 0.058 | 0.139 | MAP kinase kinase inhibitor | |||
| 0.107 | 0.026 | 0.107 | mTOR complex 2 inhibitor | |||
| 0.089 | 0.009 | 0.089 | Calcium channel P-type blocker | |||
| 0.087 | 0.008 | 0.087 | Squalene epoxidase inhibitor | |||
| 0.083 | 0.004 | 0.083 | ATP citrate lysase inhibitor | |||
| 0.084 | 0.005 | 0.084 | Alpha 1d adrenoreceptor agonist | |||
| 0.113 | 0.034 | 0.113 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.09 | 0.012 | 0.122 | Leukotriene B4 antagonist | 0.122 0.007 CID_114851 | CID_114851 | |
| 0.109 | 0.031 | 0.109 | Bromodomain-containing protein 2 inhibitor | |||
| 0.1 | 0.022 | 0.1 | Leukotriene antagonist | 0.076 0.035 CID_114851 | ||
| 0.09 | 0.012 | 0.09 | Plasminogen activator inhibitor antagonist | |||
| 0.088 | 0.011 | 0.088 | Heme oxygenase stimulant | |||
| 0.136 | 0.059 | 0.136 | Nav1.3 sodium channel blocker | |||
| 0.123 | 0.046 | 0.123 | Protein kinase (CK2) inhibitor | |||
| 0.083 | 0.007 | 0.083 | Retinoid X alpha receptor agonist | |||
| 0.088 | 0.012 | 0.088 | Sphingosine kinase 2 inhibitor | |||
| 0.095 | 0.019 | 0.095 | TRPA1 antagonist | |||
| 0.122 | 0.046 | 0.291 | Mediator release inhibitor | 0.291 0.008 CID_114851 | CID_114851 | |
| 0.104 | 0.028 | 0.126 | Na+ K+ transporting ATPase inhibitor | 0.126 0.013 CID_114851 | CID_114851 | |
| 0.078 | 0.004 | 0.078 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.131 | 0.056 | 0.152 | Beta amyloid protein antagonist | 0.152 0.039 CID_114851 | CID_114851 | |
| 0.165 | 0.091 | 0.491 | Platelet adhesion inhibitor | 0.491 0.005 CID_114851 | CID_114851 | |
| 0.224 | 0.151 | 0.471 | Interleukin 2 agonist | 0.471 0.012 CID_114851 | CID_114851 | |
| 0.089 | 0.016 | 0.089 | Exportin-1 inhibitor | |||
| 0.086 | 0.013 | 0.086 | Sphingosine kinase inhibitor | |||
| 0.087 | 0.015 | 0.087 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.144 | 0.072 | 0.144 | Activin receptor-like kinase 2 inhibitor | |||
| 0.171 | 0.099 | 0.171 | Focal adhesion kinase 2 inhibitor | |||
| 0.12 | 0.049 | 0.12 | Alpha 2c adrenoreceptor antagonist | |||
| 0.13 | 0.06 | 0.13 | Anesthetic local | |||
| 0.091 | 0.02 | 0.091 | Beta adrenoreceptor antagonist | |||
| 0.098 | 0.028 | 0.098 | Lipase inhibitor | |||
| 0.078 | 0.008 | 0.078 | Retinoid X receptor agonist | |||
| 0.09 | 0.02 | 0.09 | Protein kinase C beta inhibitor | |||
| 0.155 | 0.085 | 0.155 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.09 | 0.02 | 0.09 | 5 Hydroxytryptamine 3 agonist | |||
| 0.079 | 0.009 | 0.079 | Ryanodine receptor antagonist | |||
| 0.11 | 0.042 | 0.11 | Glutamate (mGluR7) agonist | |||
| 0.165 | 0.096 | 0.174 | P-glycoprotein inhibitor | 0.174 0.085 CID_114851 | CID_114851 | |
| 0.101 | 0.033 | 0.101 | Cathepsin G inhibitor | |||
| 0.084 | 0.016 | 0.084 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.091 | 0.023 | 0.091 | NMDA receptor agonist | |||
| 0.073 | 0.006 | 0.073 | GABA uptake inhibitor | |||
| 0.077 | 0.011 | 0.077 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.095 | 0.029 | 0.095 | Dopamine agonist | |||
| 0.069 | 0.004 | 0.069 | Estrogen-related receptor beta antagonist | |||
| 0.134 | 0.069 | 0.134 | Sodium channel (voltage-gated) blocker | |||
| 0.108 | 0.042 | 0.108 | Calcium antagonist | |||
| 0.073 | 0.008 | 0.073 | Liver X receptor alpha agonist | |||
| 0.097 | 0.032 | 0.097 | Caspase 7 inhibitor | |||
| 0.094 | 0.03 | 0.094 | Prostaglandin-E synthase inhibitor | |||
| 0.071 | 0.007 | 0.071 | Dopamine beta hydroxylase inhibitor | |||
| 0.081 | 0.017 | 0.081 | Cyclin D1 inhibitor | |||
| 0.15 | 0.087 | 0.15 | Growth hormone agonist | |||
| 0.072 | 0.009 | 0.072 | Purinergic P2X4 antagonist | |||
| 0.083 | 0.02 | 0.083 | I kappa B kinase 2 inhibitor | |||
| 0.156 | 0.093 | 0.156 | Death-associated protein kinase 2 inhibitor | |||
| 0.149 | 0.086 | 0.149 | Sigma receptor agonist | |||
| 0.072 | 0.01 | 0.072 | Immunoglobulin Fc receptor antagonist | |||
| 0.07 | 0.008 | 0.07 | Geranyltranstransferase inhibitor | |||
| 0.084 | 0.022 | 0.084 | Androgen agonist | |||
| 0.075 | 0.013 | 0.075 | Beta 2 adrenoreceptor agonist | |||
| 0.084 | 0.022 | 0.084 | Alpha 2 adrenoreceptor agonist | |||
| 0.142 | 0.08 | 0.142 | MAP kinase 3 inhibitor | |||
| 0.1 | 0.038 | 0.1 | I kappa B kinase inhibitor | |||
| 0.068 | 0.006 | 0.068 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.185 | 0.124 | 0.185 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.105 | 0.043 | 0.105 | Potassium channel activator | |||
| 0.112 | 0.052 | 0.189 | Toll-Like receptor 4 antagonist | 0.189 0.008 CID_114851 | CID_114851 | |
| 0.084 | 0.024 | 0.084 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.074 | 0.014 | 0.074 | Potassium channel Kv1.3 blocker | |||
| 0.094 | 0.034 | 0.128 | Interferon agonist | 0.128 0.014 CID_114851 | CID_114851 | |
| 0.078 | 0.018 | 0.078 | Botulinum neurotoxin type A inhibitor | |||
| 0.071 | 0.012 | 0.071 | CXC chemokine 1 receptor antagonist | |||
| 0.121 | 0.062 | 0.121 | Interleukin 1b antagonist | 0.099 0.082 CID_114851 | ||
| 0.104 | 0.045 | 0.104 | ABCA1 expression enhancer | |||
| 0.09 | 0.03 | 0.09 | Amidase inhibitor | |||
| 0.083 | 0.024 | 0.083 | 5 Hydroxytryptamine 2A agonist | |||
| 0.07 | 0.011 | 0.07 | Dihydroorotase inhibitor | |||
| 0.118 | 0.059 | 0.118 | GABA receptor agonist | |||
| 0.105 | 0.046 | 0.133 | Interleukin 12 antagonist | 0.133 0.019 CID_114851 | CID_114851 | |
| 0.074 | 0.016 | 0.074 | Dopamine D2 agonist | |||
| 0.075 | 0.016 | 0.075 | 5 Hydroxytryptamine 7 agonist | |||
| 0.14 | 0.081 | 0.14 | Neuropeptide Y1 antagonist | |||
| 0.141 | 0.084 | 0.141 | Acetylcholine M1 receptor antagonist | |||
| 0.179 | 0.122 | 0.383 | Vasodilator | 0.383 0.026 CID_114851 | CID_114851 | |
| 0.065 | 0.008 | 0.072 | Guanylate cyclase inhibitor | 0.072 0.004 CID_114851 | CID_114851 | |
| 0.071 | 0.014 | 0.085 | Adenine nucleotide translocase inhibitor | 0.085 0.007 CID_114851 | CID_114851 | |
| 0.065 | 0.008 | 0.065 | DNA gyrase subunit A inhibitor | |||
| 0.076 | 0.02 | 0.076 | Beta 1 adrenoreceptor antagonist | |||
| 0.076 | 0.02 | 0.076 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.06 | 0.005 | 0.06 | Vanilloid 3 antagonist | |||
| 0.078 | 0.023 | 0.078 | MDM2 inhibitor | |||
| 0.067 | 0.012 | 0.067 | Cholesterol esterase inhibitor | |||
| 0.137 | 0.082 | 0.137 | MAP3K9 inhibitor | |||
| 0.088 | 0.034 | 0.088 | Cyclin B3 inhibitor | |||
| 0.115 | 0.061 | 0.115 | Nav1.5 sodium channel blocker | |||
| 0.07 | 0.016 | 0.07 | Beta 2 adrenoreceptor antagonist | |||
| 0.065 | 0.012 | 0.065 | Glutamate (mGluR4) antagonist | |||
| 0.059 | 0.006 | 0.059 | Liver X receptor beta antagonist | |||
| 0.059 | 0.007 | 0.059 | Catechol O-methyltransferase inhibitor | |||
| 0.064 | 0.011 | 0.064 | Glutamate (mGluR group III) antagonist | |||
| 0.084 | 0.031 | 0.084 | Acetylcholine M5 receptor agonist | |||
| 0.059 | 0.007 | 0.059 | Kainate receptor agonist | |||
| 0.07 | 0.018 | 0.07 | Lysine-specific demethylase 1A inhibitor | |||
| 0.069 | 0.017 | 0.183 | Alpha-mannosidase inhibitor | 0.183 0.003 CID_114851 | CID_114851 | |
| 0.06 | 0.009 | 0.06 | Nerve growth factor antagonist | |||
| 0.06 | 0.01 | 0.06 | Sirtuin 2 inhibitor | |||
| 0.062 | 0.011 | 0.062 | GABA B receptor antagonist | |||
| 0.055 | 0.005 | 0.055 | CF transmembrane conductance regulator antagonist | |||
| 0.071 | 0.021 | 0.071 | Glucosylceramidase inhibitor | 0.05 0.047 CID_114851 | ||
| 0.127 | 0.077 | 0.127 | Sodium channel blocker | |||
| 0.14 | 0.09 | 0.382 | Thrombolytic | 0.382 0.013 CID_114851 | CID_114851 | |
| 0.057 | 0.008 | 0.057 | Glutamate (mGluR8) agonist | |||
| 0.073 | 0.024 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.061 | 0.013 | 0.061 | Urate transporter 1 inhibitor | |||
| 0.057 | 0.009 | 0.057 | Glutamate (mGluR3) antagonist | |||
| 0.064 | 0.017 | 0.27 | Heparanase inhibitor | 0.27 0.002 CID_114851 | CID_114851 | |
| 0.051 | 0.004 | 0.051 | Leukotriene B4 receptor 2 antagonist | 0.031 0.008 CID_114851 | ||
| 0.056 | 0.009 | 0.056 | Retinoid X receptor antagonist | |||
| 0.066 | 0.019 | 0.066 | Leukotriene C antagonist | |||
| 0.052 | 0.006 | 0.136 | Sodium/glucose cotransporter 2 inhibitor | 0.136 0.002 CID_114851 | CID_114851 | |
| 0.057 | 0.011 | 0.057 | Fumarate hydratase inhibitor | 0.043 0.017 CID_114851 | ||
| 0.05 | 0.004 | 0.05 | Thyroid hormone agonist | |||
| 0.066 | 0.021 | 0.066 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.104 | 0.059 | 0.104 | Bronchodilator | |||
| 0.053 | 0.008 | 0.053 | Free fatty acid receptor 1 antagonist | |||
| 0.239 | 0.194 | 0.239 | Transcription factor inhibitor | |||
| 0.09 | 0.046 | 0.09 | Vanilloid agonist | |||
| 0.073 | 0.029 | 0.073 | Carbonic anhydrase stimulant | |||
| 0.087 | 0.043 | 0.087 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.056 | 0.012 | 0.056 | Nicotinic acid receptor agonist | |||
| 0.165 | 0.122 | 0.355 | Hypolipemic | 0.355 0.034 CID_114851 | CID_114851 | |
| 0.05 | 0.007 | 0.05 | Leukotriene B4 receptor 1 antagonist | 0.028 0.02 CID_114851 | ||
| 0.06 | 0.017 | 0.199 | Mannosidase inhibitor | 0.199 0.003 CID_114851 | CID_114851 | |
| 0.065 | 0.022 | 0.114 | Carbonic anhydrase XIV inhibitor | 0.114 0.008 CID_114851 | CID_114851 | |
| 0.055 | 0.012 | 0.055 | Sphingosine kinase 1 inhibitor | |||
| 0.055 | 0.012 | 0.055 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.067 | 0.025 | 0.067 | Cannabinoid CB2 receptor antagonist | |||
| 0.05 | 0.009 | 0.05 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.049 | 0.008 | 0.049 | Protein kinase (CK2) beta inhibitor | |||
| 0.045 | 0.004 | 0.045 | Estrogen-related receptor gamma antagonist | |||
| 0.081 | 0.04 | 0.081 | Phosphodiesterase VI inhibitor | 0.079 0.043 CID_114851 | ||
| 0.123 | 0.083 | 0.123 | Toll-Like receptor 9 antagonist | |||
| 0.051 | 0.011 | 0.051 | Delayed rectifier potassium channel blocker | |||
| 0.072 | 0.032 | 0.096 | Interferon inducer | 0.096 0.014 CID_114851 | CID_114851 | |
| 0.089 | 0.049 | 0.089 | Inducible nitric-oxide synthase inhibitor | |||
| 0.078 | 0.037 | 0.078 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.044 | 0.004 | 0.044 | Hedgehog signaling activator | |||
| 0.044 | 0.004 | 0.044 | Alpha 2a adrenoreceptor agonist | |||
| 0.051 | 0.012 | 0.051 | Heme oxygenase inhibitor | |||
| 0.056 | 0.017 | 0.056 | AICAR transformylase inhibitor | |||
| 0.047 | 0.009 | 0.052 | Uridine phosphorylase inhibitor | 0.052 0.007 CID_114851 | CID_114851 | |
| 0.046 | 0.01 | 0.046 | Ceramide glucosyltransferase inhibitor | 0.041 0.015 CID_114851 | ||
| 0.059 | 0.022 | 0.059 | Adenosine deaminase inhibitor | 0.051 0.029 CID_114851 | ||
| 0.083 | 0.046 | 0.083 | Alpha 2a adrenoreceptor antagonist | |||
| 0.05 | 0.014 | 0.05 | Diamine oxidase inhibitor | |||
| 0.236 | 0.2 | 0.236 | DNA directed DNA polymerase inhibitor | |||
| 0.129 | 0.093 | 0.129 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.04 | 0.004 | 0.064 | Vanilloid 2 agonist | 0.064 0.002 CID_114851 | CID_114851 | |
| 0.057 | 0.022 | 0.057 | Oleamide hydrolase inhibitor | |||
| 0.105 | 0.07 | 0.125 | Multidrug resistance-associated protein 1 inhibitor | 0.125 0.043 CID_114851 | CID_114851 | |
| 0.037 | 0.003 | 0.054 | Antibiotic Anthracycline-like | 0.054 0.001 CID_114851 | CID_114851 | |
| 0.055 | 0.021 | 0.055 | Thymidylate synthase inhibitor | |||
| 0.055 | 0.021 | 0.055 | Oxytocin agonist | |||
| 0.049 | 0.015 | 0.049 | Retinoic acid alpha receptor agonist | |||
| 0.107 | 0.074 | 0.107 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.04 | 0.007 | 0.148 | Sodium/glucose cotransporter inhibitor | 0.148 0.002 CID_114851 | CID_114851 | |
| 0.057 | 0.024 | 0.057 | Potassium channel (Inward rectifier) activator | |||
| 0.064 | 0.032 | 0.064 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.134 | 0.101 | 0.134 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.062 | 0.03 | 0.062 | Ornithine carbamoyltransferase inhibitor | |||
| 0.041 | 0.009 | 0.041 | Glutamate (mGluR3) agonist | |||
| 0.059 | 0.028 | 0.059 | 5 Hydroxytryptamine 2 agonist | |||
| 0.084 | 0.053 | 0.084 | Opioid kappa receptor antagonist | |||
| 0.05 | 0.018 | 0.05 | Beta adrenoreceptor agonist | |||
| 0.053 | 0.022 | 0.053 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.233 | 0.202 | 0.233 | DNA polymerase beta inhibitor | |||
| 0.085 | 0.054 | 0.085 | GABA A receptor agonist | |||
| 0.073 | 0.043 | 0.073 | Alpha adrenoreceptor agonist | |||
| 0.044 | 0.013 | 0.044 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.046 | 0.016 | 0.046 | Phosphoglycerate kinase inhibitor | |||
| 0.054 | 0.023 | 0.054 | Potassium channel (ATP-sensitive) activator | |||
| 0.066 | 0.036 | 0.066 | Phosphodiesterase 1C inhibitor | |||
| 0.043 | 0.013 | 0.043 | Liver X receptor beta agonist | |||
| 0.054 | 0.024 | 0.054 | Carbonic anhydrase VII inhibitor | |||
| 0.034 | 0.004 | 0.034 | Nicotinic acid receptor 1 antagonist | |||
| 0.059 | 0.03 | 0.059 | Epithelial sodium channel blocker | |||
| 0.034 | 0.005 | 0.034 | Complement factor 1s inhibitor | |||
| 0.057 | 0.027 | 0.057 | Vanilloid 2 antagonist | |||
| 0.048 | 0.019 | 0.048 | Progesterone antagonist | |||
| 0.039 | 0.01 | 0.039 | Liver X receptor alpha antagonist | |||
| 0.042 | 0.013 | 0.042 | Retinoid X alpha receptor antagonist | |||
| 0.047 | 0.019 | 0.047 | Dihydropteroate synthase inhibitor | |||
| 0.035 | 0.007 | 0.035 | Prostaglandin F2 alpha agonist | |||
| 0.062 | 0.034 | 0.062 | Bcl-xL inhibitor | |||
| 0.065 | 0.037 | 0.065 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.073 | 0.045 | 0.073 | Secretase beta inhibitor | |||
| 0.037 | 0.009 | 0.037 | Purinergic P2Y15 antagonist | |||
| 0.048 | 0.021 | 0.048 | Thymidine kinase inhibitor | |||
| 0.032 | 0.005 | 0.032 | Thyroid hormone alpha antagonist | |||
| 0.06 | 0.033 | 0.06 | Bombesin 3 receptor antagonist | |||
| 0.058 | 0.031 | 0.058 | Thromboxane synthase inhibitor | |||
| 0.034 | 0.007 | 0.034 | Glutamate (mGluR1a) agonist | |||
| 0.045 | 0.019 | 0.075 | Arginase inhibitor | 0.075 0.007 CID_114851 | CID_114851 | |
| 0.051 | 0.026 | 0.067 | Cytokine production stimulant | 0.067 0.009 CID_114851 | CID_114851 | |
| 0.035 | 0.01 | 0.035 | CXC chemokine 2 receptor antagonist | |||
| 0.039 | 0.014 | 0.039 | Glucagon receptor antagonist | |||
| 0.094 | 0.07 | 0.094 | Nitric-oxide synthase inhibitor | |||
| 0.053 | 0.029 | 0.053 | AMPA receptor antagonist | |||
| 0.094 | 0.07 | 0.094 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.044 | 0.02 | 0.044 | TRPM8 blocker | |||
| 0.047 | 0.023 | 0.047 | CDK5/p25 inhibitor | |||
| 0.033 | 0.009 | 0.033 | Nicotinic acid receptor 2 antagonist | |||
| 0.038 | 0.015 | 0.038 | Liver X receptor antagonist | |||
| 0.04 | 0.016 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.038 | 0.015 | 0.038 | Cholesterol ester transfer protein antagonist | |||
| 0.074 | 0.052 | 0.074 | Adenosine A3 receptor antagonist | |||
| 0.069 | 0.046 | 0.069 | Sirtuin 1 inhibitor | |||
| 0.027 | 0.005 | 0.027 | NMDA receptor phencyclidine site antagonist | |||
| 0.042 | 0.02 | 0.042 | Leukotriene C4 antagonist | |||
| 0.027 | 0.005 | 0.027 | Alpha 2b adrenoreceptor agonist | |||
| 0.03 | 0.009 | 0.03 | Dopamine D1 agonist | 0.029 0.009 CID_114851 | ||
| 0.044 | 0.023 | 0.044 | Acid-sensing ion channel blocker | |||
| 0.043 | 0.022 | 0.043 | AMPA 4 receptor antagonist | |||
| 0.084 | 0.064 | 0.091 | Interleukin 5 antagonist | 0.091 0.053 CID_114851 | CID_114851 | |
| 0.028 | 0.008 | 0.028 | Imidazoline I1 receptor antagonist | |||
| 0.076 | 0.056 | 0.076 | Metalloproteinase-2 inhibitor | |||
| 0.036 | 0.016 | 0.036 | Prostaglandin agonist | |||
| 0.059 | 0.039 | 0.059 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.025 | 0.005 | 0.025 | Estrogen-related receptor gamma agonist | |||
| 0.09 | 0.07 | 0.09 | Butyrylcholinesterase inhibitor | |||
| 0.024 | 0.005 | 0.024 | Thyroid hormone alpha agonist | |||
| 0.056 | 0.036 | 0.056 | Thromboxane antagonist | |||
| 0.048 | 0.028 | 0.048 | Purinergic P2Y antagonist | |||
| 0.044 | 0.026 | 0.044 | Angiotensin AT1 receptor antagonist | |||
| 0.025 | 0.007 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.085 | 0.067 | 0.085 | Phosphodiesterase I inhibitor | |||
| 0.11 | 0.091 | 0.11 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.052 | 0.034 | 0.052 | Thromboxane A2 antagonist | |||
| 0.022 | 0.004 | 0.022 | Antibiotic Tetracycline-like | |||
| 0.036 | 0.018 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.03 | 0.013 | 0.03 | Dopamine autoreceptor agonist | |||
| 0.04 | 0.022 | 0.04 | Kainate receptor 2 antagonist | |||
| 0.031 | 0.014 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.08 | 0.063 | 0.08 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.081 | 0.064 | 0.081 | Alpha 2 adrenoreceptor antagonist | |||
| 0.029 | 0.013 | 0.029 | Thymidine phosphorylase inhibitor | |||
| 0.037 | 0.021 | 0.037 | RNA-directed RNA polymerase inhibitor | |||
| 0.036 | 0.02 | 0.036 | Purinergic P2Y2 antagonist | |||
| 0.033 | 0.017 | 0.033 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.026 | 0.01 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CID_114851 | ||
| 0.024 | 0.008 | 0.024 | Retinoid X beta receptor antagonist | |||
| 0.029 | 0.014 | 0.029 | Prostaglandin H2 antagonist | |||
| 0.021 | 0.006 | 0.03 | Telomerase stimulant | 0.03 0.003 CID_114851 | CID_114851 | |
| 0.07 | 0.055 | 0.07 | Metalloproteinase-9 inhibitor | |||
| 0.048 | 0.033 | 0.048 | Aldosterone antagonist | |||
| 0.185 | 0.171 | 0.185 | MAP kinase kinase 3 inhibitor | |||
| 0.02 | 0.005 | 0.02 | Egl nine homolog 1 inhibitor | |||
| 0.06 | 0.045 | 0.06 | Cannabinoid CB1 receptor antagonist | |||
| 0.091 | 0.077 | 0.091 | Gastric antisecretory | |||
| 0.019 | 0.004 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.04 | 0.026 | 0.04 | VCAM-1 antagonist | |||
| 0.028 | 0.014 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.049 | 0.035 | 0.049 | Potassium channel (Inward rectifier) blocker | |||
| 0.058 | 0.044 | 0.058 | Acetylcholine M3 receptor antagonist | |||
| 0.062 | 0.048 | 0.062 | Neutrophil collagenase inhibitor | |||
| 0.04 | 0.026 | 0.04 | VCAM antagonist | |||
| 0.112 | 0.098 | 0.112 | Toll-Like receptor antagonist | |||
| 0.031 | 0.017 | 0.031 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.026 | 0.012 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.024 | 0.011 | 0.024 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.058 | 0.045 | 0.058 | Phosphodiesterase 1B inhibitor | |||
| 0.06 | 0.048 | 0.06 | Histone deacetylase SIRT3 inhibitor | |||
| 0.023 | 0.011 | 0.023 | Retinoic acid alpha receptor antagonist | |||
| 0.041 | 0.028 | 0.041 | Kainate receptor antagonist | |||
| 0.101 | 0.089 | 0.101 | Acetylcholine muscarinic antagonist | |||
| 0.039 | 0.027 | 0.039 | 5 Hydroxytryptamine 2B agonist | |||
| 0.028 | 0.015 | 0.028 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.04 | 0.028 | 0.04 | Erythropoietin receptor agonist | |||
| 0.034 | 0.022 | 0.034 | Melatonin 2 agonist | |||
| 0.037 | 0.026 | 0.037 | Integrin alpha2 antagonist | |||
| 0.026 | 0.015 | 0.026 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.032 | 0.021 | 0.032 | HCV NS5B polymerase inhibitor | |||
| 0.121 | 0.11 | 0.121 | Death-associated protein kinase 1 inhibitor | |||
| 0.08 | 0.069 | 0.08 | Opioid antagonist | |||
| 0.049 | 0.038 | 0.049 | Prolyl endopeptidase inhibitor | |||
| 0.047 | 0.037 | 0.047 | Bombesin 2 receptor antagonist | |||
| 0.054 | 0.044 | 0.054 | Adenosine A1 receptor antagonist | |||
| 0.014 | 0.004 | 0.014 | Thyroid hormone beta agonist | |||
| 0.015 | 0.005 | 0.015 | Egl nine homolog 3 inhibitor | |||
| 0.022 | 0.012 | 0.022 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.19 | 0.181 | 0.19 | Thioredoxin glutathione reductase inhibitor | |||
| 0.025 | 0.016 | 0.025 | Glutamate (mGluR1) agonist | |||
| 0.022 | 0.012 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.049 | 0.04 | 0.118 | Glucose-6-phosphate translocase inhibitor | 0.118 0.004 CID_114851 | CID_114851 | |
| 0.037 | 0.028 | 0.037 | Farnesoid X receptor agonist | |||
| 0.057 | 0.048 | 0.057 | Opioid delta receptor antagonist | |||
| 0.051 | 0.042 | 0.051 | GABA receptor antagonist | |||
| 0.038 | 0.029 | 0.038 | Dopamine D3 agonist | |||
| 0.033 | 0.025 | 0.033 | Angiotensin II receptor antagonist | |||
| 0.053 | 0.045 | 0.053 | Plasminogen activator inhibitor | |||
| 0.024 | 0.015 | 0.024 | Prostaglandin E2 agonist | |||
| 0.026 | 0.018 | 0.026 | Integrin alpha2beta1 antagonist | |||
| 0.053 | 0.045 | 0.053 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.023 | 0.015 | 0.023 | Beta 1 adrenoreceptor agonist | |||
| 0.063 | 0.055 | 0.063 | Potassium channel (ATP-sensitive) blocker | |||
| 0.032 | 0.024 | 0.032 | Estrogen-related receptor alpha antagonist | |||
| 0.038 | 0.03 | 0.038 | Membrane dipeptidase inhibitor | |||
| 0.017 | 0.009 | 0.017 | Thromboxane A2 agonist | |||
| 0.019 | 0.012 | 0.019 | Alpha 2c adrenoreceptor agonist | |||
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | |||
| 0.023 | 0.016 | 0.023 | Prostaglandin EP2 agonist | |||
| 0.056 | 0.049 | 0.056 | Acetylcholine M5 receptor antagonist | |||
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | |||
| 0.071 | 0.064 | 0.071 | Somatostatin 1 agonist | |||
| 0.11 | 0.104 | 0.11 | Histone deacetylase SIRT1 inhibitor | |||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | |||
| 0.042 | 0.035 | 0.125 | Phosphorylase inhibitor | 0.125 0.009 CID_114851 | CID_114851 | |
| 0.072 | 0.065 | 0.072 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.024 | 0.018 | 0.024 | NMDA receptor glycine site antagonist | |||
| 0.026 | 0.02 | 0.026 | Calcium-sensing receptor agonist | |||
| 0.011 | 0.005 | 0.011 | Progesterone receptor A antagonist | |||
| 0.023 | 0.018 | 0.079 | Protein 30S ribosomal subunit inhibitor | 0.079 0.004 CID_114851 | CID_114851 | |
| 0.039 | 0.034 | 0.039 | Carbonic anhydrase IV inhibitor | |||
| 0.026 | 0.021 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.018 | 0.013 | 0.018 | Retinoic acid receptor antagonist | |||
| 0.042 | 0.037 | 0.042 | Glycine transporter 2 inhibitor | |||
| 0.135 | 0.13 | 0.144 | Lipocortins synthesis antagonist | 0.144 0.115 CID_114851 | CID_114851 | |
| 0.017 | 0.012 | 0.055 | Ileal bile acid transport inhibitor | 0.055 0.003 CID_114851 | CID_114851 | |
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.015 | 0.01 | 0.015 | Calcium-sensing receptor antagonist | |||
| 0.008 | 0.004 | 0.008 | DNA topoisomerase III inhibitor | |||
| 0.022 | 0.017 | 0.022 | Retinoic acid gamma receptor agonist | |||
| 0.041 | 0.037 | 0.041 | Histamine H1 receptor agonist | |||
| 0.059 | 0.056 | 0.059 | Prolactin release inhibitor | |||
| 0.048 | 0.044 | 0.048 | GABA A receptor antagonist | |||
| 0.016 | 0.013 | 0.016 | G-protein-coupled receptor 120 agonist | |||
| 0.038 | 0.035 | 0.038 | Plasmepsin II inhibitor | |||
| 0.116 | 0.113 | 0.116 | Cholinergic | |||
| 0.019 | 0.016 | 0.019 | Retinoic acid beta receptor agonist | |||
| 0.041 | 0.038 | 0.041 | Dihydrofolate reductase inhibitor | |||
| 0.029 | 0.027 | 0.029 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.048 | 0.046 | 0.048 | Protein kinase C eta inhibitor | |||
| 0.136 | 0.133 | 0.136 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.035 | 0.033 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.02 | 0.019 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.055 | 0.054 | 0.055 | Phosphodiesterase 1A inhibitor | |||
| 0.061 | 0.06 | 0.061 | Cannabinoid receptor antagonist | |||
| 0.046 | 0.045 | 0.065 | Factor III inhibitor | 0.065 0.014 CID_114851 | CID_114851 | |
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.243 | 0.242 | 0.243 | MAP kinase 1 inhibitor | |||
| 0.011 | 0.01 | 0.011 | Retinoic acid beta receptor antagonist | |||
| 0.035 | 0.034 | 0.035 | Potassium channel Kv1.1 blocker | |||
| 0.009 | 0.01 | 0.014 | Purinergic P2Y2 agonist | 0.014 0.004 CID_114851 | CID_114851 | |
| 0.057 | 0.061 | 0.132 | Neuraminidase (influenza) inhibitor | 0.132 0.009 CID_114851 | CID_114851 | |
| 0.062 | 0.066 | 0.123 | Histone deacetylase stimulant | 0.123 0.016 CID_114851 | CID_114851 | |
| 0.062 | 0.066 | 0.123 | Histone deacetylase SIRT1 stimulant | 0.123 0.016 CID_114851 | CID_114851 | |
| 0.04 | 0.046 | 0.083 | Carbonic anhydrase XII inhibitor | 0.083 0.024 CID_114851 | CID_114851 | |
| 0.051 | 0.058 | 0.492 | Selectin antagonist | 0.492 0.003 CID_114851 | CID_114851 | |
| 0.049 | 0.073 | 0.075 | Lipocortins synthesis agonist | 0.075 0.017 CID_114851 | CID_114851 | |
| 0.038 | 0.067 | 0.128 | Factor IXa inhibitor | 0.128 0.005 CID_114851 | CID_114851 | |
| 0.031 | 0.06 | 0.055 | Carbonic anhydrase IX inhibitor | 0.055 0.039 CID_114851 | CID_114851 | |
| 0.021 | 0.051 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 CID_114851 | CID_114851 | |
| 0.039 | 0.074 | 0.108 | Neuraminidase inhibitor | 0.108 0.013 CID_114851 | CID_114851 | |
| 0.025 | 0.067 | 0.097 | Antibiotic Aminoglycoside-like | 0.097 0.003 CID_114851 | CID_114851 | |
| 0.032 | 0.081 | 0.075 | Prostaglandin EP2 antagonist | 0.075 0.03 CID_114851 | CID_114851 | |
| 0.01 | 0.065 | 0.022 | Corticosteroid-like | 0.022 0.014 CID_114851 | CID_114851 | |
| 0.04 | 0.104 | 0.058 | Transcription factor AP-1 inhibitor | 0.058 0.049 CID_114851 | CID_114851 | |
| 0.08 | 0.152 | 0.403 | Cell adhesion inhibitor | 0.403 0.005 CID_114851 | CID_114851 | |
| 0.008 | 0.087 | 0.05 | Squalene synthetase inhibitor | 0.05 0.014 CID_114851 | CID_114851 | |
| 0.025 | 0.104 | 0.067 | Neuraminidase (Influenza A) inhibitor | 0.067 0.009 CID_114851 | CID_114851 | |
| 0.025 | 0.107 | 0.147 | Protein 50S ribosomal subunit inhibitor | 0.147 0.007 CID_114851 | CID_114851 | |
| 0.002 | 0.107 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 CID_114851 | CID_114851 | |
| 0.028 | 0.14 | 0.078 | Nitric oxide donor | 0.078 0.024 CID_114851 | CID_114851 | |
| 0.047 | 0.181 | 0.095 | Falcipain 2 inhibitor | 0.095 0.056 CID_114851 | CID_114851 | |
| 0.048 | 0.184 | 0.097 | Falcipain inhibitor | 0.097 0.057 CID_114851 | CID_114851 | |
| 0.089 | 0.246 | 0.387 | Platelet antagonist | 0.387 0.03 CID_114851 | CID_114851 | |
| 0.02 | 0.178 | 0.053 | Microtubule stabilization | 0.053 0.024 CID_114851 | CID_114851 | |
| 0.052 | 0.213 | 0.172 | Transcription factor NF kappa B stimulant | 0.172 0.012 CID_114851 | CID_114851 | |
| 0.027 | 0.206 | 0.067 | DNA gyrase inhibitor | 0.067 0.04 CID_114851 | CID_114851 | |
| 0.015 | 0.219 | 0.04 | Toll-Like receptor 4 agonist | 0.04 0.005 CID_114851 | CID_114851 | |
| 0.105 | 0.322 | 0.349 | Angiogenesis inhibitor | 0.349 0.071 CID_114851 | CID_114851 | |
| 0.038 | 0.264 | 0.221 | Cell adhesion molecule inhibitor | 0.221 0.008 CID_114851 | CID_114851 | |
| 0.039 | 0.36 | 0.297 | Anticoagulant | 0.297 0.029 CID_114851 | CID_114851 | |
| 0.005 | 0.354 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.011 CID_114851 | CID_114851 | |
| 0.066 | 0.466 | 0.217 | Antiobesity | 0.217 0.19 CID_114851 | CID_114851 | |
| 0.005 | 0.458 | 0.025 | Motilin receptor agonist | 0.025 0.013 CID_114851 | CID_114851 | |
| 0.059 | 0.529 | 0.524 | Immunomodulator | 0.524 0.02 CID_114851 | CID_114851 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |